60 Degrees Pharmaceuticals, Inc. Warrant

NASDAQ SXTPW
$0.07 0.0000 7.38%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 23.75 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
33.88K
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-3.27M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
1.47M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
135.02 %

Upcoming events 60 Degrees Pharmaceuticals, Inc. Warrant

All events
No upcoming events scheduled

Stock chart 60 Degrees Pharmaceuticals, Inc. Warrant

Stock analysis 60 Degrees Pharmaceuticals, Inc. Warrant

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
- -1.30
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
0.0100 1.15
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
0.32 -0.75
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.32 0.42
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-249.48 -50.00

Price change 60 Degrees Pharmaceuticals, Inc. Warrant per year

0.01$ 0.15$
Min Max

Summary analysis 60 Degrees Pharmaceuticals, Inc. Warrant

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure 60 Degrees Pharmaceuticals, Inc. Warrant

Revenue and net income 60 Degrees Pharmaceuticals, Inc. Warrant

All parameters

About company 60 Degrees Pharmaceuticals, Inc. Warrant

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
Address:
Company name: 60 Degrees Pharmaceuticals, Inc. Warrant
Issuer ticker: SXTPW
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2023-07-12
Sector: Healthcare
Industry: Biotechnology
Site: